Contact Us
Global
中国 Global
Patient Avatars, Precision Treatment!

BUDcare® Patient-Derived Tumor Organoid Drug Sensitivity Test Service

This service is aimed to find the most effective anti-tumor drug for patient. Using patient-derived tumor organoids, a panel of anti-tumor drugs were screened for their anti-tumor capability. The BUDcare® response score will assist clinicians to set up individualized treatment strategies for each patient within the therapeutic time window.

BUDcare® Service has been included in precision medicine testing programs of many national medical centers. Diverse large cohort clinical studies using the data generated by BUDcare® services are ongoing, among which several cutting-edge research results have been published in international academic journals. Details
Procedures
The whole procedure takes 14 days on average!
Obtaining fresh tumor tissue or malignant fluid containing tumor cells (cancer associated pleural and ascitic fluid etc)
01
Generating patient-derived tumor organoids
02
Screening anti-tumor drugs using tumor organoids (drugs include single-targeted drug, single chemotherapy drug, or combination of both)
03
Obtaining anti-tumor drug sensitivity test results and providing a scientific testing report
04
Applications
Selecting preferred adjuvant or neoadjuvant chemotherapy regimen
Selecting preferred single targeted drug and/or chemotherapy-targeted combination regimen
Searching potential therapeutic regimen by screening new drugs or drugs in clinical trials after drug resistant
Searching potential therapeutic regimen for patient without targetable genetic mutations
Excluding ineffective therapeutic regimens
Clinical Benefits
Applying the organoid technology for individualized medicine and maximizing the clinical benefit for each patient!
Drug screening test of patient-derived tumor organoid in vitro
Patient-derived tumor organoids, highly recapitulate the tumor characteristics of cancer patients, therefore the drug response scores obtained from this invitro drug screening test represent the clinical outcome in reality.
Provide scientific supporting data for precise medicine
Conducting drug sensitivity tests for single or combination drug treatments with chemotherapy drug and/or targeted drug, and providing scientific supporting data.
Reduce the risk of drug resistance
Providing efficient prioritized therapeutic regime and decreasing the risk of using inefficient drug regime, thereby reducing the risk of drug resistance.
Time-Saving
Helping clinician to set up an effective anti-tumor therapy as soon as possible within a limited therapeutic time window.
Message Board
Please select the type of service
attachment（Each file size limit is 20MB，file format jpg,png,gif,jpeg,bmp,pdf,mp3,mp4,doc,docx,csv,xls,xlsx,ppt,pptx,zip,7z,rar,tar）

Click or drag file to upload

Get code 60s